Tecovirimat — Drug Intelligence | 2 EU Trials

Filter these 2 trials by condition, phase, country and more.

2 Registered trials

0 Recruiting

2 Completed trials

2 Sponsors

9 Countries

Phase IV

Phase IV: 2

Oversight events:

1 corrective measure across 1 trial

Indications tested

2 total

European randomised clinical trial on mPOX Infection (EPOXI) Ended

2022-501979-10-00 Phase IV 8 countries University Medical Center Utrecht
Cohort study of human mpox virus disease Ended

2022-501132-42-00 Phase IV 8 countries University Of Oxford

Showing 1–2 of 2 trials